Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FLUOROCHEM.NS Stock Summary
Top 10 Correlated ETFs
FLUOROCHEM.NS
In the News
FLUOROCHEM.NS Financial details
Company Rating
Buy
Market Cap
343.01B
Income
6.66B
Revenue
46.19B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.06%
Employees
3.31K
Optionable
No
Shortable
Yes
Earnings
03 May 2024
P/E
40.52
Forward P/E
34.86
PEG
-28.56
P/S
7.35
P/B
6.45
P/C
-
P/FCF
-
Quick Ratio
0.56
Current Ratio
1.39
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
60.61
EPS next Y
88.85
EPS next Q
32.5
EPS this Y
70.52%
EPS next Y
46.58%
EPS next 5Y
96.97%
EPS last 5Y
-75.06%
Revenue last 5Y
15.81%
Revenue Q/Q
4.75%
EPS Q/Q
51.88%
-
-
-
-
SMA20
-13.06%
SMA50
-9.21%
SMA100
14.21%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
32%
ROC
0.22%
Gross Margin
53%
Oper. Margin
27%
Profit Margin
18%
Payout
-
Shs Outstand
109.85M
Shs Float
32.97M
-
-
-
-
Target Price
-
52W Range
2537.0-3920.0
52W High
-20.99%
52W Low
+22.09%
RSI
36
Rel Volume
0.37
Avg Volume
113.7K
Volume
41.8K
Perf Week
-5.2%
Perf Month
-10.63%
Perf Quarter
8.85%
Perf Half Y
2.99%
-
-
-
-
Beta
0.511
-
-
Volatility
29.56%, 217.73%
Prev Close
-0.23%
Price
3097.35
Change
-1.01%
FLUOROCHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 272.93K | 237.27 | 241.28 | 350.52 | 517.49 | |
Net income per share | 124.86K | 17.87 | -19.91 | 71.66 | 120.97 | |
Operating cash flow per share | 78.18K | 49.74 | 56.11 | 67.49 | 67.26 | |
Free cash flow per share | 26.13K | -59.14 | 31.2 | 6.13 | 0.69 | |
Cash per share | 4.09K | 7.65 | 8.19 | 15.63 | 49.21 | |
Book value per share | 351.02K | 338.24 | 317.96 | 387.36 | 502.57 | |
Tangible book value per share | 343.67K | 335.55 | 315.57 | 384.38 | 499.71 | |
Share holders equity per share | 351.02K | 338.24 | 317.96 | 387.36 | 502.57 | |
Interest debt per share | 101.49K | 165.1 | 153.89 | 147.76 | 148.56 | |
Market cap | 71.4M | 31.42B | 63.18B | 301.27B | 331.77B | |
Enterprise value | 9.34B | 48.49B | 78.92B | 316.54B | 346.68B | |
P/E ratio | 0.01 | 16 | -28.89 | 38.27 | 24.97 | |
Price to sales ratio | 0 | 1.21 | 2.38 | 7.82 | 5.84 | |
POCF ratio | 0.01 | 5.75 | 10.25 | 40.64 | 44.9 | |
PFCF ratio | 0.03 | -4.84 | 18.43 | 447.3 | 4.4K | |
P/B Ratio | 0 | 0.85 | 1.81 | 7.08 | 6.01 | |
PTB ratio | 0 | 0.85 | 1.81 | 7.08 | 6.01 | |
EV to sales | 0.34 | 1.86 | 2.98 | 8.22 | 6.1 | |
Enterprise value over EBITDA | 1.05 | 6.75 | 10.35 | 24.23 | 16.22 | |
EV to operating cash flow | 1.19 | 8.88 | 12.8 | 42.7 | 46.92 | |
EV to free cash flow | 3.58 | -7.46 | 23.03 | 469.97 | 4.6K | |
Earnings yield | 174.87 | 0.06 | -0.03 | 0.03 | 0.04 | |
Free cash flow yield | 36.59 | -0.21 | 0.05 | 0 | 0 | |
Debt to equity | 0.28 | 0.46 | 0.45 | 0.36 | 0.27 | |
Debt to assets | 0.2 | 0.28 | 0.27 | 0.23 | 0.18 | |
Net debt to EBITDA | 1.04 | 2.38 | 2.06 | 1.17 | 0.7 | |
Current ratio | 1.17 | 1.05 | 1.08 | 1.28 | 1.5 | |
Interest coverage | 14.03 | 3.67 | 3.79 | 13.78 | 14.81 | |
Income quality | 0.63 | 2.89 | -2.78 | 0.96 | 0.56 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0.03 | 0.03 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.67 | -2.19 | -0.44 | -0.91 | -0.99 | |
Capex to revenue | -0.19 | -0.46 | -0.1 | -0.18 | -0.13 | |
Capex to depreciation | -3.17 | -6.22 | -1.35 | -3.28 | -3.1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 993.03K | 368.81 | 377.41 | 790.29 | 1.17K | |
ROIC | 0.28 | 0.03 | -0.04 | 0.12 | 0.18 | |
Return on tangible assets | 0.26 | 0.03 | -0.04 | 0.11 | 0.16 | |
Graham Net | -52.2K | -100.52 | -113.3 | -97.72 | -63.41 | |
Working capital | 2.03B | 837.81M | 1.35B | 5.32B | 11.59B | |
Tangible asset value | 34.37B | 36.86B | 34.67B | 42.22B | 54.89B | |
Net current asset value | -43.32M | -4.35B | -5.66B | -2.1B | 6.47B | |
Invested capital | 0.28 | 0.46 | 0.45 | 0.36 | 0.27 | |
Average receivables | 0 | 8.63B | 9.94B | 11.02B | 12B | |
Average payables | 0 | 2.99B | 3.53B | 4.26B | 6.02B | |
Average inventory | 0 | 7.27B | 8.38B | 9.06B | 12.16B | |
Days sales outstanding | 94.09 | 143.3 | 132.81 | 117.41 | 74.55 | |
Days payables outstanding | 66.14 | 96.53 | 91.94 | 98 | 99.85 | |
Days of inventory on hand | 183.33 | 213.72 | 234.53 | 180.78 | 214.64 | |
Receivables turnover | 3.88 | 2.55 | 2.75 | 3.11 | 4.9 | |
Payables turnover | 5.52 | 3.78 | 3.97 | 3.72 | 3.66 | |
Inventory turnover | 1.99 | 1.71 | 1.56 | 2.02 | 1.7 | |
ROE | 0.36 | 0.05 | -0.06 | 0.18 | 0.24 | |
Capex per share | -52.06K | -108.88 | -24.91 | -61.36 | -66.58 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 129.5 | 133.95 | 110.08 | 86.19 | 90.28 | |
Net income per share | 30.09 | 30.21 | 18.31 | 4.8 | 7.29 | |
Operating cash flow per share | 10.98 | 11.61 | 11.93 | 12.3 | 13.09 | |
Free cash flow per share | 10.98 | 11.61 | 11.93 | 12.3 | 13.09 | |
Cash per share | 14.18 | 49.21 | 14.67 | 54.14 | 0 | |
Book value per share | 444.55 | 502.57 | 502.57 | 523.53 | 0 | |
Tangible book value per share | 0 | 499.71 | 0 | 520.03 | 0 | |
Share holders equity per share | 444.55 | 502.57 | 502.57 | 523.53 | 0 | |
Interest debt per share | 3.48 | 141.1 | 2.55 | 154.62 | 3.39 | |
Market cap | 340.6B | 331.77B | 322.12B | 335.04B | 418.83B | |
Enterprise value | 342.15B | 346.68B | 323.73B | 351.44B | 418.83B | |
P/E ratio | 25.85 | 24.99 | 40.03 | 158.82 | 130.74 | |
Price to sales ratio | 24.02 | 22.55 | 26.64 | 35.39 | 42.23 | |
POCF ratio | 283.4 | 260.09 | 245.82 | 247.99 | 291.3 | |
PFCF ratio | 283.4 | 260.09 | 245.82 | 247.99 | 291.3 | |
P/B Ratio | 7 | 6.01 | 5.83 | 5.83 | 0 | |
PTB ratio | 7 | 6.01 | 5.83 | 5.83 | 0 | |
EV to sales | 24.13 | 23.56 | 26.77 | 37.12 | 42.23 | |
Enterprise value over EBITDA | 62.82 | 63.28 | 89.31 | 199.01 | 190.91 | |
EV to operating cash flow | 284.7 | 271.78 | 247.05 | 260.13 | 291.3 | |
EV to free cash flow | 284.7 | 271.78 | 247.05 | 260.13 | 291.3 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.27 | 0 | 0.29 | 0 | |
Debt to assets | 0 | 0.18 | 0 | 0.19 | 0 | |
Net debt to EBITDA | 0.29 | 2.72 | 0.44 | 9.29 | 0 | |
Current ratio | 0 | 1.5 | 0 | 1.39 | 0 | |
Interest coverage | 12.71 | 13.91 | 9.69 | 3.19 | 3.96 | |
Income quality | 0.36 | 0.38 | 0.65 | 2.56 | 1.8 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 548.61 | 584.48 | 455.04 | 237.81 | 0 | |
ROIC | 0.07 | 0.05 | 0.04 | 0.01 | 0 | |
Return on tangible assets | 0 | 0.04 | 0 | 0.01 | 0 | |
Graham Net | 14.18 | -63.41 | 14.67 | -81.32 | 0 | |
Working capital | 1.55B | 11.59B | 1.61B | 9.44B | 0 | |
Tangible asset value | 0 | 54.89B | 0 | 57.13B | 0 | |
Net current asset value | 1.55B | 6.47B | 1.61B | 4.55B | 0 | |
Invested capital | 0 | 0.27 | 0 | 0.29 | 0 | |
Average receivables | 5.56B | 5.81B | 5.81B | 3.79B | 3.79B | |
Average payables | 3.33B | 3.46B | 3.46B | 3.07B | 3.07B | |
Average inventory | 5.87B | 7.43B | 7.43B | 8.31B | 8.31B | |
Days sales outstanding | 0 | 71.02 | 0 | 72.1 | 0 | |
Days payables outstanding | 0 | 96.07 | 0 | 105.44 | 0 | |
Days of inventory on hand | 0 | 206.51 | 0 | 284.81 | 0 | |
Receivables turnover | 0 | 1.27 | 0 | 1.25 | 0 | |
Payables turnover | 0 | 0.94 | 0 | 0.85 | 0 | |
Inventory turnover | 0 | 0.44 | 0 | 0.32 | 0 | |
ROE | 0.07 | 0.06 | 0.04 | 0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
FLUOROCHEM.NS Frequently Asked Questions
What is Gujarat Fluorochemicals Limited stock symbol ?
Gujarat Fluorochemicals Limited is a IN stock and trading under the symbol FLUOROCHEM.NS
What is Gujarat Fluorochemicals Limited stock quote today ?
Gujarat Fluorochemicals Limited stock price is $3097.35 today.
Is Gujarat Fluorochemicals Limited stock public?
Yes, Gujarat Fluorochemicals Limited is a publicly traded company.